Karonudib

N/A

Report date: 2025/03/06 11:51:37
NME

Base Information

Drug NameKaronudib
Drug Alias NameTH-1579OXC-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxidized purine nucleoside triphosphate hydrolase inhibitors
TargetsOxidized purine nucleoside triphosphate hydrolase
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThomas Helledays Stiftelse för Medicinsk Forskning
China Registration ClassN/A

Develop Information

Active CompaniesOxcia AB
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A